US 11512066
Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseases
granted A61KA61K31/454A61K31/4545
Quick answer
US patent 11512066 (Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseases) held by Takeda Pharmaceutical Company Limited expires Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Nov 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 1
- CPC classes
- A61K, A61K31/454, A61K31/4545, A61K45/06, A61P